Ingavirin Forte

N/A

Report date: 2026/02/25 20:02:36

Base Information

Drug NameIngavirin Forte

Drug Alias NameCombined preparation of imidazolylethylamide of pentanedioic acid and N,N'-bis-[2-(1,3-diazocyclopenta-2,4-dien-4-yl)ethyl] diamide of malonic acid

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHaematopoiesis stimulantsNeutrophils stimulantsApoptosis inhibitors +[4]

TargetsNot applicable

Therapy Area/IndicationsRespirovirus InfectionsInfluenza, HumanRespiratory Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsYes Ingavirin

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesValenta Pharm Jsc

China Registration ClassN/A

Develop Information

Active CompaniesValenta Pharm Jsc

Inactive CompaniesN/A

Active IndicationsRespirovirus InfectionsInfluenza, HumanRespiratory Tract Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A